Sumatriptan And Naproxen Sodium Tablet, Film Coated
Product Images NDC 65862-928

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan And Naproxen Sodium (NDC 65862-928). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sumanap Fig1)

The text describes a chart showing the percentage of adult patients who experienced relief from headache pain within two hours of taking different medications or placebo. The medications shown in the chart are Sumatriptan and Naproxen Sodium tablets with a dosage of 85/500 mg, Sumatriptan with a dosage of 85 mg, Naproxen Sodium with a dosage of 500 mg, and a placebo. The chart shows the percentage of subjects who achieved relief over time, with time measured in hours post-dose.*

FDA Label Image

Figure 2 (Sumanap Fig2)

FDA Label Image

Package Label.principal Display Panel (Sumanap Fig3)

This is a medication containing Sumatriptan Succinate USP and Naproxen Sodium USP pills formulated for oral administration. These tablets are film-coated. Each tablet has a strength of 119 mg which is equivalent to 8 mg of sumatriptan. The pack also contains 500 mg of naproxen sodium USP. The usual dosage is indicated on the prescribing information provided by the manufacturer, Aurobindo Pharma US. The pills come in a package with a blister and a patient medication guide. Store the tablets between 20°C to 25°C (66°F to 77°F). There is a code area for printing on the packaging cover.*

FDA Label Image

Chemical Structure (Sumanap Str1)

FDA Label Image

Chemical Structure (Sumanap Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.